Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
de Jong W, Aerts J, Allard S, Brander C, Buyze J, Florence E, van Gorp E, Vanham G, Leal L, Mothe B, Thielemans K, Plana M, Garcia F, Gruters R; iHIVARNA consortium. de Jong W, et al. Among authors: buyze j. Trials. 2019 Jun 17;20(1):361. doi: 10.1186/s13063-019-3409-1. Trials. 2019. PMID: 31208472 Free PMC article. Clinical Trial.
Risk factors for HCV acquisition among HIV-positive MSM in Belgium.
Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, Kenyon C, Florence E, Buvé A. Apers L, et al. Among authors: buyze j. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):585-93. doi: 10.1097/QAI.0000000000000528. J Acquir Immune Defic Syndr. 2015. PMID: 25763786
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.
Jong W, Leal L, Buyze J, Pannus P, Guardo A, Salgado M, Mothe B, Molto J, Moron-Lopez S, Gálvez C, Florence E, Vanham G, Gorp EV, Brander C, Allard S, Thielemans K, Martinez-Picado J, Plana M, García F, Gruters RA. Jong W, et al. Among authors: buyze j. Vaccines (Basel). 2019 Dec 6;7(4):209. doi: 10.3390/vaccines7040209. Vaccines (Basel). 2019. PMID: 31817794 Free PMC article.
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
de Jong W, Aerts J, Allard S, Brander C, Buyze J, Florence E, van Gorp E, Vanham G, Leal L, Mothe B, Thielemans K, Plana M, Garcia F, Gruters R; iHIVARNA consortium. de Jong W, et al. Among authors: buyze j. Trials. 2019 Dec 13;20(1):721. doi: 10.1186/s13063-019-3940-0. Trials. 2019. PMID: 31836017 Free PMC article.
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
Van Dijck C, Tsoumanis A, Rotsaert A, Vuylsteke B, Van den Bossche D, Paeleman E, De Baetselier I, Brosius I, Laumen J, Buyze J, Wouters K, Lynen L, Van Esbroeck M, Herssens N, Abdellati S, Declercq S, Reyniers T, Van Herrewege Y, Florence E, Kenyon C. Van Dijck C, et al. Among authors: buyze j. Lancet Infect Dis. 2021 May;21(5):657-667. doi: 10.1016/S1473-3099(20)30778-7. Epub 2021 Mar 4. Lancet Infect Dis. 2021. PMID: 33676596 Clinical Trial.
The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic.
De Baetselier I, Apers L, Platteau T, Buyze J, Florence E, Kenyon C, Van den Bossche D; NRC-STI research group. De Baetselier I, et al. Among authors: buyze j. Int J STD AIDS. 2021 Oct;32(11):998-1003. doi: 10.1177/09564624211013289. Epub 2021 Jun 5. Int J STD AIDS. 2021. PMID: 34096386
79 results